Adrian P L Smith Selected Research

flutemetamol

1/2021	Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent.
11/2019	Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
10/2018	Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition.
1/2017	Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.
12/2016	Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
8/2015	[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.
3/2015	Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian P L Smith Research Topics

Disease

6	Amyloid Plaque 01/2021 - 03/2015
6	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2015
5	Death (Near-Death Experience) 10/2018 - 03/2015
4	Dementia (Dementias) 01/2020 - 08/2015
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2019 - 12/2016
1	Body Weight (Weight, Body) 01/2017
1	Atrophy 12/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2016
1	Pituitary Neoplasms (Pituitary Adenoma) 02/2003
1	Pulmonary Hypertension 03/2002

Drug/Important Bio-Agent (IBA)

7	flutemetamolIBA 01/2021 - 03/2015
7	Amyloid (Amyloid Fibrils)IBA 01/2020 - 03/2015
2	Peptides (Polypeptides)IBA 01/2020 - 11/2019
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	GadoliniumIBA 01/2017
1	gadodiamide (Omniscan)FDA Link 01/2017
1	FluorineIBA 03/2015
1	phaeomelaninIBA 02/2003
1	alpha-MSHIBA 02/2003
1	eumelaninIBA 02/2003
1	Messenger RNA (mRNA)IBA 03/2002
1	Endothelin-1 (Endothelin 1)IBA 03/2002